Skip to main content

Drug-to-Antibody Ratio (DAR) by UV/Vis Spectroscopy

  • Protocol
  • First Online:
Antibody-Drug Conjugates

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1045))

Abstract

UV/Vis spectroscopy is a simple and convenient method to determine protein concentrations as well as the average number of drugs that are conjugated to the antibody in an antibody–drug conjugate (ADC). Using the measured absorbances of the ADC and the extinction coefficients of the antibody and the drug, the average drug-to-antibody ratio (DAR) can be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wakankar A, Chen Y, Gokarn Y (2011) Analytical methods for physicochemical characterization of antibody drug conjugates. MAbs 3:161–172

    Article  PubMed  Google Scholar 

  2. Hamblett KJ, Senter PD, Chace DF et al (2004) Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Clin Cancer Res 10:7063–7070

    Article  PubMed  CAS  Google Scholar 

  3. Hinman LM, Hamann PR, Wallace R et al (1993) Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics. Cancer Res 53:3336–3342

    PubMed  CAS  Google Scholar 

  4. Siegel MM, Hollander IJ, Hamann PR et al (1991) Matrix-assisted UV-laser desorption/ionization mass spectrometric analysis of monoclonal antibodies for the determination of carbohydrate, conjugated chelator and conjugated drug content. Anal Chem 63:2470–2481

    Article  PubMed  CAS  Google Scholar 

  5. Lazar AC, Wang L, Blattler WA et al (2005) Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry. Rapid Commun Mass Spectrom 19:1806–1814

    Article  PubMed  CAS  Google Scholar 

  6. Schoonheydt RA (2010) UV-VIS-NIR spectroscopy and microscopy of heterogeneous catalysts. Chem Soc Rev 39:5051–5066

    Article  PubMed  CAS  Google Scholar 

  7. Pretsch E, Bühlmann P, Badertscher M (2009) Structure determination of organic compounds, tables of spectral data, 4th edn. Springer, New York, pp 401–420

    Google Scholar 

  8. Schmid F (2001) Biological macromolecules: UV-visible spectrophotometry. Encyclopedia Life sci. doi:10.1038/npg.els.0003142

    Google Scholar 

  9. Wang L, Amphlett G, Blattler WA et al (2005) Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry. Protein Sci 14:2436–2446

    Article  PubMed  CAS  Google Scholar 

  10. Hudecz F, Garnett MC, Khan T et al (1992) The influence of synthetic conditions on the stability of methotrexate-monoclonal antibody conjugates determined by reversed phase high performance liquid chromatography. Biomed Chromatogr 6:128–132

    Article  PubMed  CAS  Google Scholar 

  11. Chari RV, Jackel KA, Bourret LA et al (1995) Enhancement of the selectivity and antitumor efficacy of a CC-1065 analogue through immunoconjugate formation. Cancer Res 55:4079–4084

    PubMed  CAS  Google Scholar 

  12. Greenfield RS, Kaneko T, Daues A et al (1990) Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker. Cancer Res 50:6600–6607

    PubMed  CAS  Google Scholar 

  13. Willner D, Trail PA, Hofstead SJ et al (1993) (6-Maleimidocaproyl)hydrazone of doxorubicin—a new derivative for the preparation of immunoconjugates of doxorubicin. Bioconjug Chem 4:521–527

    Article  PubMed  CAS  Google Scholar 

  14. Moran J (2002) Presentation at 224th American Chemical Society National Meeting, 18–22 Aug, Boston, MA

    Google Scholar 

  15. Laguzza BC, Nichols CL, Briggs SL et al (1989) New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation and representative in vivo activity. J Med Chem 32:548–555

    Article  PubMed  CAS  Google Scholar 

  16. Benson AM, Suruda AJ, Talalay P (1975) Concentration-dependent association of A-3-ketosteroid isomerase of Pseudomonas testosteroni. J Biol Chem 250:276–280

    PubMed  CAS  Google Scholar 

  17. Jaenicke L (1974) A rapid micromethod for the determination of nitrogen and phosphate in biological material. Anal Biochem 61:623–627

    Article  PubMed  CAS  Google Scholar 

  18. Pace CN, Vajdos F, Fee L et al (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4:2411–2423

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Pat Rancatore, Richard Seipert, Boyan Zhang, and Andrea Ji for comments and help in preparing this review.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Chen, Y. (2013). Drug-to-Antibody Ratio (DAR) by UV/Vis Spectroscopy. In: Ducry, L. (eds) Antibody-Drug Conjugates. Methods in Molecular Biology, vol 1045. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-541-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-541-5_16

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-540-8

  • Online ISBN: 978-1-62703-541-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics